SMS Pharmaceuticals Limited has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. The certificate was received from M/s. Aarthi Consultants Private Limited, the company's Registrar and Share Transfer Agent. This filing confirms compliance with the regulations, indicating that the dematerialization of securities received from depository participants has been processed within 15 days. The actions taken include the mutilation and cancellation of original certificates, and the substitution of the depository's name as the registered owner in the company's records. These securities are listed on the relevant stock exchanges.
